Novavax Inc. buy BTIG Research
Start price
12.06.26
/
50%
€7.90
Target price
12.06.27
€16.42
Performance (%)
-13.04%
Price
07.08.26
€6.87
Summary
This prediction is currently active. The prediction for Novavax Inc. disappoints with a performance of -13.04%. This prediction currently runs until 12.06.27. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novavax Inc. | 8.189% | 8.189% |
| iShares Core DAX® | 2,57 % | 3,50 % |
| iShares Nasdaq 100 | 4,86 % | 0,65 % |
| iShares Nikkei 225® | 5,59 % | -0,25 % |
| iShares S&P 500 | 3,25 % | 2,08 % |
Comments by BTIG_Research for this prediction
In the thread Novavax Inc. diskutieren
Novavax (NVAX) had its "buy" rating reaffirmed by BTIG Research. They now have a $19.00 price target on the stock.
Ratings data for NVAX provided by MarketBeat